(210) | Number of the EPO application | 15813831 |
(220) | Filing date of the EPO application | 2015.12.18 |
(80) | EPO patent specification publication (B) | EPB nr. 06/2019, 2019.02.06 |
(110) | EPO patent number | 3237406 |
(11) | Number of the document | MD 3237406 T2 |
(21) | Number of the application | e 2017 0225 |
(71) | Name(s) of applicant(s), code of the country | Galapagos NV, BE; Les Laboratoires Servier, FR; |
(72) | Name(s) of inventor(s), code of the country | BREBION Franck Laurent, FR; ALVEY Luke Jonathan, FR; AMANTINI David, FR; DEPREZ Pierre Marc Marie Joseph, FR; GOSMINI Romain Luc Marie, FR; JARY Helène Marie, FR; PEIXOTO Christophe, FR; VARIN Marie Laurence Claire, FR; DE CEUNINCK Frédéric André, FR; POP-BOTEZ Iuliana Ecaterina, FR; |
(73) | Name(s) of owner(s), code of the country | GALAPAGOS NV, BE; |
(54) | Title of the invention | 5-[(Piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | C07D 403/06 (2006.01.01); A61K 31/496 (2006.01.01); A61P 19/02 (2006.01.01); A61P 19/04 (2006.01.01) |
(19) | Country | BE |
(41) | Date of publication of the application | 2018.01.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2019.05.31 |
(30) | Priority | 14307129, 2014.12.22, EP |
(74) | Patent attorney | (Procedură) MARGINE Ion, Str. Lomonosov nr. 43, ap. 23, MD-2009, Chişinău, Republica Moldova |
| Assignment contract | Nr. şi data deciziei: | 3861, 14.03.2022 | Nr. şi data contractului: | 3530, 14.03.2022 | Cedent(i): | GALAPAGOS NV
Generaal De Wittelaan L11/A3
2800 Mechelen, BE
LES Laboratoires Servier
35, Rue de Verdun
92284 Suresnes, FR
| Cesionar(i): | GALAPAGOS NV
Generaal De Wittelaan L11/A3
2800 Mechelen, BE
|
|
(86) | International application | PCT/EP2015/080430, 2015.12.18 |
(87) | International publication | WO 2016/102347, 2016.06.30 |